← Pharming Group N.V.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $135.1m |
$169.0m
+25.08%
|
$185.7m
+9.86%
|
$198.9m
+7.10%
|
$205.6m
+3.39%
|
$245.3m
+19.30%
|
$297.2m
+21.15%
|
$376.1m
+26.56%
|
$366.5m
-2.57%
|
|
| Cost of Goods and Services Sold | $109.4m |
$21.4m
-80.47%
|
$20.6m
-3.53%
|
$21.1m
+2.63%
|
$17.6m
-16.93%
|
$25.2m
+43.56%
|
$35.4m
+40.41%
|
$45.5m
+28.53%
|
$49.4m
+8.56%
|
|
| Cost Of Revenue | $109.4m |
$21.4m
-80.47%
|
$20.6m
-3.53%
|
$21.1m
+2.63%
|
$17.6m
-16.93%
|
$25.2m
+43.56%
|
$35.4m
+40.41%
|
$45.5m
+28.53%
|
$49.4m
+8.56%
|
|
| Reconciled Cost Of Revenue | — | — | — | — | $11.5m |
$18.4m
+59.98%
|
$28.7m
+55.56%
|
$43.5m
+51.60%
|
$49.4m
+13.57%
|
|
| Costs of sales | ($22.2m) |
($21.4m)
+3.72%
|
($20.6m)
+3.53%
|
($21.1m)
-2.63%
|
($17.6m)
+16.93%
|
($25.2m)
-43.56%
|
($35.4m)
-40.41%
|
($45.5m)
-28.53%
|
— | |
| Net Interest Income | — | — | — | — | ($5.4m) |
($2.4m)
+54.72%
|
($5.1m)
-108.87%
|
($8.7m)
-71.82%
|
($8.4m)
+4.44%
|
|
| Gross Profit | $113.0m |
$147.7m
+30.74%
|
$165.1m
+11.80%
|
$177.7m
+7.65%
|
$188.1m
+5.81%
|
$220.1m
+17.04%
|
$261.8m
+18.94%
|
$330.6m
+26.29%
|
$317.1m
-4.10%
|
|
| Research and development | ($28.9m) | $28.4m | $33.7m | $70.4m | $52.5m | $68.9m | $83.1m | $100.4m | $113.3m | |
| Selling And Marketing Expense | — | — | — | — | $6.4m | $6.8m | $7.1m | $6.7m | $97.9m | |
| General and administrative | ($12.2m) | $18.9m | $21.1m | $37.0m | $46.0m | $55.9m | $70.7m | $80.0m | $98.0m | |
| General And Administrative Expense | — | — | — | — | $62.4m | $80.7m | $92.1m | $110.8m | $98.0m | |
| Restructuring And Mergern Acquisition | — | — | — | $0 | $0 | — | — | — | $0 | |
| Operating expenses: | ||||||||||
| Other Operating Costs | ($75.6m) | ($87.2m) | ($100.0m) | ($166.8m) | ($184.3m) | ($248.8m) | ($272.6m) | ($311.3m) | — | |
| Other Operating Expenses | — | — | — | — | $49.7m | $76.8m | $73.7m | $82.7m | — | |
| EBIT | $20.3m | ($6.0m) | $245k | $23.6m | $26.8m | |||||
| Other Non Operating Income Expenses | — | — | — | — | $507k | $286k | $71k | $1.6m | — | |
| Interest Expense | — | $0 | — | — | $5.4m | $6.0m | $8.7m | $10.7m | $11.0m | |
| Interest Expense On Lease Liabilities | — | $662k | $670k | $795k | $622k | $1.1m | $1.0m | $1.0m | $11.0m | |
| Interest Income | — | — | — | — | $85k | $3.7m | $4.9m | $2.2m | $2.7m | |
| Net Non Operating Interest Income Expense | — | — | — | — | ($5.4m) | ($2.4m) | ($5.1m) | ($8.7m) | ($8.4m) | |
| Fair value gain (loss) on revaluation | ($495k) | ($209k) | $60k | $114k | ($1.2m) | ($930k) | $5.0m | $2.3m | — | |
| Gain On Sale Of Business | — | — | — | — | $12.2m | $0 | $0 | — | $0 | |
| Gain On Sale Of PPE | — | — | — | — | $0 | $21.3m | $0 | $0 | $0 | |
| Gain On Sale Of Security | — | — | — | — | $3.2m | ($3.9m) | $7.0m | ($4.9m) | $5.0m | |
| Other Income | $684k | $435k | $1.6m | $2.6m | $14.5m | $23.3m | $2.2m | $6.5m | — | |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | $0 | $229k | $317k | $694k | ($1.1m) | ($289k) | ($1.8m) | $623k | — | |
| Share of net profits / (loss) in associates using the equity method | $0 | $229k | $317k | $694k | ($1.1m) | ($289k) | ($1.8m) | $623k | — | |
| Other Income Expense | — | — | — | — | $10.5m | $12.7m | $259k | $704k | $10.3m | |
| Pre-Tax Income | $857k | $46.7m | $38.6m | $23.1m | $15.0m | ($12.0m) | ($8.5m) | $12.8m | $15.8m | |
| Current Tax Expense (Income) | — | $4.3m | $2.4m | $97k | $3.8m | $5.3m | $9.3m | $7.7m | — | |
| Income Tax Expense Continuing Operations | $24.1m | $10.5m | $5.6m | $7.1m | $1.3m | ($1.5m) | $3.3m | $10.3m | $6.5m | |
| Net Income From Continuing And Discontinued Operation | — | — | — | — | $13.7m | ($10.5m) | ($11.8m) | $2.9m | $9.3m | |
| Basic Earnings (Loss) Per Share | $0.04 | $0.06 | $0.05 | $0.03 | $0.02 | ($0.02) | ($0.02) | $0.00 | $0.14 | |
| Diluted Earnings (Loss) Per Share | $0.04 | $0.05 | $0.05 | $0.02 | $0.02 | ($0.02) | ($0.02) | $0.00 | $0.14 | |
| Basic Average Shares | — | — | — | — | $65.1m | $67.5m | $68.8m | $71.3m | $70.3m | |
| Diluted Average Shares | — | — | — | — | $72.0m | $67.5m | $68.8m | $71.3m | $74.9m | |
| Additional Financial Items | ||||||||||
| Applicable Tax Rate | — | — | — | — | — | — | — | $0 | — | |
| Average Effective Tax Rate | — | — | — | — | — | — | — | $1 | — | |
| Depreciation Right of Use Assets | — | $1.5m | $1.8m | $2.8m | $3.0m | $3.7m | $3.4m | $3.0m | $9.2m | |
| Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill | — | $732k | $0 | ($5.0m) | $0 | $253k | $0 | — | — | |
| Profit Loss Attributable To Noncontrolling Interests | — | — | — | — | — | — | — | ($313k) | — | |
| Profit Loss Attributable To Owners Of Parent | — | — | — | — | — | — | — | $2.9m | — | |
| Profit Loss Before Tax | $857k | $46.7m | $38.6m | $23.1m | $15.0m | ($12.0m) | ($8.5m) | $12.8m | — | |
| Profit Loss From Operating Activities | $38.0m | $60.9m | $66.7m | $13.6m | $18.2m | ($5.4m) | ($8.6m) | $25.8m | — | |
| Tax Rate Effect Of Foreign Tax Rates | — | — | — | — | — | — | — | ($0) | — | |
| Marketing and sales | ($34.5m) | ($39.9m) | ($45.2m) | ($59.4m) | ($85.8m) | ($124.0m) | ($118.8m) | ($131.0m) | — | |
| Operating profit / (loss) | $38.0m |
$60.9m
+60.32%
|
$66.7m
+9.58%
|
$13.6m
-79.68%
|
$18.2m
+34.45%
|
($5.4m)
-129.55%
|
($8.6m)
-60.03%
|
$25.8m
+399.76%
|
— | |
| Other finance income | $18k | $1.0m | $626k | $14.9m | $4.5m | $3.7m | $6.8m | $2.2m | — | |
| Profit / (loss) for the year | $25.0m | $36.2m | $33.0m | $16.0m | $13.7m | ($10.5m) | ($11.8m) | $2.5m | — | |
| Equity holders of the parent | — | — | — | — | — | ($10.5m) | ($11.8m) | $2.9m | — | |
| Non-controlling interests | — | — | — | — | — | $0 | $0 | ($313k) | — | |
| Amortization | — | — | — | — | $4.3m | $5.6m | $6.0m | $6.3m | $6.3m | |
| Depreciation Amortization Depletion Income Statement | — | — | — | — | $7.2m | $9.2m | $9.4m | $9.2m | $9.2m | |
| Depreciation And Amortization In Income Statement | — | — | — | — | $7.2m | $9.2m | $9.4m | $9.2m | $9.2m | |
| Depreciation Income Statement | — | — | — | — | $2.9m | $3.5m | $3.3m | $2.9m | $9.2m | |
| Diluted EPS | — | — | — | — | $0.19 | ($0.15) | ($0.16) | $0.04 | $0.14 | |
| Diluted NI Availto Com Stockholders | — | — | — | — | $13.7m | ($10.5m) | ($11.8m) | $2.9m | $9.3m | |
| Earnings From Equity Interest | $0 | $229k | $317k | $694k | ($1.1m) | ($289k) | ($1.8m) | $623k | $783k | |
| Impairment Of Capital Assets | — | — | — | — | $4.4m | $4.7m | $5.0m | $491k | $491k | |
| Minority Interests | — | — | — | — | — | $0 | $0 | $313k | $0 | |
| Normalized EBITDA | — | — | — | — | $22.5m | ($2.8m) | $14.4m | $36.3m | $38.9m | |
| Normalized Income | — | — | — | — | $3.6m | ($21.7m) | ($13.3m) | $4.0m | $4.3m | |
| Other Gand A | — | — | — | — | $14.7m | $15.0m | $17.8m | $18.3m | — | |
| Reconciled Depreciation | — | — | — | — | $13.2m | $15.9m | $16.1m | $11.2m | $9.2m | |
| Salaries And Wages | — | — | — | — | $47.7m | $65.7m | $74.3m | $92.5m | $92.5m | |
| Selling General And Administration | — | — | — | — | $68.9m | $87.5m | $99.2m | $117.4m | — | |
| Special Income Charges | — | — | — | — | $7.9m | $16.6m | ($5.0m) | $3.4m | $3.4m | |
| Tax Effect Of Unusual Items | — | — | — | — | $971k | $1.5m | $503k | ($385k) | $3.3m | |
| Tax Provision | $24.1m | $10.5m | $5.6m | $7.1m | $1.3m | ($1.5m) | $3.3m | $10.3m | $6.5m | |
| Tax Rate For Calcs | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Depreciation And Amortisation Expense | — | $4.5m | $5.3m | $6.4m | — | — | — | — | $9.2m | |
| Employee Benefits Expense | — | $35.8m | $45.0m | $60.8m | $68.3m | $92.5m | $104.2m | $127.4m | — | |
| Expense From Share-Based Payment Transactions With Employees | — | $4.4m | $7.4m | $9.1m | $6.4m | $9.3m | $11.3m | $13.8m | — | |
| Finance Costs | — | $0 | $65k | $94k | $105k | $134k | $56k | $196k | — | |
| Other Finance Cost | — | $15.3m | $29.2m | $6.2m | $5.5m | $9.1m | $9.9m | $18.1m | — | |
| Postemployment Benefit Expense Defined Benefit Plans | — | $1.6m | $1.6m | $2.2m | $2.3m | $3.0m | $3.6m | $4.6m | — | |
| Other finance expenses | ($36.7m) | ($15.3m) | ($29.2m) | ($6.2m) | ($5.5m) | ($9.1m) | ($9.9m) | ($18.1m) | — | |
| Finance (cost) / gain, net | ($37.1m) | ($14.5m) | ($28.5m) | $8.8m | ($2.2m) | ($6.3m) | $1.9m | ($13.6m) | — | |
| Operating Expense | — | — | — | — | $178.2m | $242.4m | $265.5m | $309.8m | $303.2m | |
| Total Unusual Items | — | — | — | — | $11.1m | $12.7m | $1.9m | ($1.5m) | $8.4m | |
| Total Expenses | — | — | — | — | $195.8m | $267.6m | $300.9m | $355.3m | $352.6m | |
| Total Other Finance Cost | — | — | — | — | $105k | $134k | $1.2m | $196k | $92k |